Table A4.

Unadjusted Associations Between Participant Characteristics and Survey Results

Variable	Want Testing		Likely to Disclose Tier-One Results		Likely to Disclose Tier-Two Results		Likely to Use Tier-One Results to Inform Treatment Recommendations		Likely to Use Tier-Two Results to Inform Treatment Recommendations		Agree With Policy to Prohibit Return of Tier-Three Results
	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI	OR	95% CI
Years since medical school	1.04	0.88 to 1.22	1.11	0.91 to 1.35	1.03	0.88 to 1.21	1.05	0.89 to 1.23	1.16	0.94 to 1.43	1.10	0.93 to 1.31
Sex (female v male)	0.83	0.40 to 1.72	0.73	0.34 to 1.59	0.75	0.38 to 1.48	1.06	0.54 to 2.09	0.50	0.19 to 1.34	2.09*	1.01 to 4.36
Type of physician (v surgical specialist)
Medical oncologist	1.97	0.93 to 4.18	1.63	0.71 to 3.71	0.60	0.29 to 1.22	0.96	0.47 to 1.96	0.58	0.23 to 1.46	0.75	0.36 to 1.58
Radiation oncologist	0.55	0.17 to 1.77	1.46	0.45 to 4.77	0.54	0.19 to 1.50	1.05	0.38 to 2.87	0.78	0.21 to 2.83	1.18	0.36 to 1.58
Researcher	1.31	0.55 to 3.13	0.91	0.34 to 2.45	0.60	0.26 to 1.38	0.76	0.33 to 1.74	0.67	0.24 to 1.85	0.80	0.33 to 1.95
No. of new patients each month	1.01	0.98 to 1.05	1.00	0.96 to 1.04	0.99	0.96 to 1.02	0.99	0.96 to 1.02	1.01	0.97 to 1.05	1.02	0.98 to 1.05
Percentage of patients tested at baseline	1.03†	1.01 to 1.04	1.02*	1.01 to 1.04	1.02‡	1.01 to 1.03	1.01	1.00 to 1.02	1.01	1.00 to 1.03	0.99*	0.97 to 1.00
Percentage of patients recommended for phase one	1.03‡	1.01 to 1.05	1.02	0.99 to 1.04	1.01	1.00 to 1.03	1.02*	1.00 to 1.04	1.02	1.00 to 1.04	0.99	0.97 to 1.00
Confidence in genomics	3.26†	1.84 to 5.77	2.00‡	1.22 to 3.26	1.54	0.98 to 2.41	1.70*	1.06 to 2.72	1.95	0.99 to 3.85	0.44‡	0.26 to 0.75

Abbreviation: OR, odds ratio.

^*P < .05.

^†P < .001.

^‡P < .01.